NCT01383837 HIV/STI Prevention for Adolescents With Substance Use Disorders in Treatment Status COMPLETED Phase PHASE1/PHASE2
NCT01378910 Genotypic Tropism Testing In Proviral Dna To Guide CCR5 Antagonist Treatment In Subjects With Undetectable HIV-1 Viremia Status COMPLETED Phase PHASE4
NCT01377857 HIV Screening Take-up: Evaluating Incentives and Opt-out Strategies Status COMPLETED Phase NA
NCT01377168 Naltrexone for Medication Compliance Among HIV-infected Men With Alcohol Use Disorder Status COMPLETED Phase PHASE4
NCT01376570 Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment Status COMPLETED Phase NA
NCT01372605 Trial of Collaborative Depression Care Management for HIV Patients Status COMPLETED Phase NA
NCT01367236 Changes in Cerebral Function in Treatment Naive HIV-1 Infected Subjects Commencing Either Boosted Atazanavir With Truvada or Boosted Darunavir With Maraviroc and Kivexa Status COMPLETED Phase PHASE4
NCT01366690 The PeerCARE Study (Peer Community-based Assistant in REtention) Status COMPLETED Phase NA
NCT01366495 A Randomized Controlled Trial of HIV Testing and Linkage to Care at Community Corrections Status COMPLETED Phase NA
NCT01354210 Text Messaging Intervention to Improve ART Adherence Among HIV-positive Youth Status COMPLETED Phase NA
NCT01350544 Treatment Advocacy Intervention for HIV-Positive African Americans Status COMPLETED Phase NA
NCT01348763 The Maraviroc Darunavir/Ritonavir Once Daily Pharmacokinetic Study Status COMPLETED Phase PHASE1
NCT01346982 Drug Interactions Between Silimarine and Darunavir/Ritonavir Status COMPLETED Phase PHASE4
NCT01346878 Antiretroviral Resistance Detection by Ultrasensitive Pyrosequencing of the HIV-1 Genome and Virological Response to Antiretroviral Rescue Treatment Status COMPLETED Phase N/A
NCT01343225 Effect of a Non-tenofovir, Non-efavirenz-based HIV Regimen on Bone Density and Vitamin D Levels in African-American Patients With HIV Infection Status UNKNOWN Phase PHASE4